June 11, 2020 / 11:44 AM / a month ago

BRIEF-Takeda Pharmaceutical Enters Into Agreement To Divest Portfolio Of Select Non-Core OTC And Prescription Pharmaceutical Products

June 11 (Reuters) - Takeda Pharmaceutical:

* TAKEDA PHARMACEUTICAL - HAS ENTERED INTO AGREEMENT TO DIVEST PORTFOLIO OF SELECT NON-CORE OTC AND PRESCRIPTION PHARMACEUTICAL PRODUCTS TO CELLTRION

* TAKEDA PHARMACEUTICAL - WILL RECEIVE $266 MILLION USD UPFRONT IN CASH AND UP TO AN ADDITIONAL $12 MILLION USD IN POTENTIAL MILESTONE PAYMENTS

* TAKEDA PHARMACEUTICAL - CO, CELLTRION HAVE ALSO ENTERED INTO MANUFACTURING AND SUPPLY AGREEMENT Source text: (reut.rs/2UywtRj) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below